Correlation Between Akari Therapeutics and Gelesis Holdings
Can any of the company-specific risk be diversified away by investing in both Akari Therapeutics and Gelesis Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akari Therapeutics and Gelesis Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akari Therapeutics PLC and Gelesis Holdings, you can compare the effects of market volatilities on Akari Therapeutics and Gelesis Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akari Therapeutics with a short position of Gelesis Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akari Therapeutics and Gelesis Holdings.
Diversification Opportunities for Akari Therapeutics and Gelesis Holdings
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Akari and Gelesis is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Akari Therapeutics PLC and Gelesis Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gelesis Holdings and Akari Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akari Therapeutics PLC are associated (or correlated) with Gelesis Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gelesis Holdings has no effect on the direction of Akari Therapeutics i.e., Akari Therapeutics and Gelesis Holdings go up and down completely randomly.
Pair Corralation between Akari Therapeutics and Gelesis Holdings
If you would invest (100.00) in Gelesis Holdings on September 1, 2024 and sell it today you would earn a total of 100.00 from holding Gelesis Holdings or generate -100.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Akari Therapeutics PLC vs. Gelesis Holdings
Performance |
| Timeline |
| Akari Therapeutics PLC |
| Gelesis Holdings |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Akari Therapeutics and Gelesis Holdings Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akari Therapeutics and Gelesis Holdings
The main advantage of trading using opposite Akari Therapeutics and Gelesis Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akari Therapeutics position performs unexpectedly, Gelesis Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gelesis Holdings will offset losses from the drop in Gelesis Holdings' long position.| Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
| Gelesis Holdings vs. Triton International Limited | Gelesis Holdings vs. U Haul Holding | Gelesis Holdings vs. HE Equipment Services | Gelesis Holdings vs. Datadog |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |